Manufacturer Supply Related Intermediates:
4-Fluorophenylboronic Acid CAS: 1765-93-1
2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone CAS: 32384-65-9
5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene CAS: 1030825-20-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1
CAS: 842133-18-0
CAS: 928672-86-0
Chemical Name |
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
CAS Number |
898566-17-1 |
CAT Number |
RF-PI1501 |
Stock Status |
In Stock, Production Scale Up to Tons |
Molecular Formula |
C18H14FIS |
Molecular Weight |
408.27 |
Melting Point |
109.0~110.0℃ |
Brand |
Ruifu Chemical |
Item |
Specifications |
Appearance |
White to Pale Yellow Crystalline Powder |
Purity / Analysis Method |
>98.0% (HPLC) |
Loss on Drying |
<1.00% |
Total Impurities |
<2.00% |
Test Standard |
Enterprise Standard |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene (CAS: 898566-17-1) is an antidiabetic agent and an intermediate of API (CAS: 842133-18-0). (CAS: 842133-18-0) is a sodium/glucose cotransporter 2 (SGLT2) inhibitor and a candidate for the treatment of type 2 diabetes and obesity. (CAS: 842133-18-0) is a once daily oral diabetes drug, which works by inhibiting sodium glucose co-transporter 2 (SGLT2) as a new drug. (CAS: 842133-18-0) can lower blood glucose levels by interdicting the blood glucose reabsorption of the kidneys and increasing the excretion of blood glucose in urine. It is the first FDA approved inhibitor for SGLT2 and used to treat adult patients with type 2 diabetes.